Patient and Caregiver Experiences With and Perceptions of Risk Evaluation and Mitigation Strategy Programs With Elements to Assure Safe Use.
Journal:
JAMA Netw Open
5(1):e2144386
Publish Date:
2022-01-04
Author Profiles:
Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies.
Journal:
Hastings Cent Rep
52(1):51-58
Publish Date:
2022-01-01
Author Profiles:
Population-Based Screening of Newborns: Findings From the NBS Expansion Study (Part One).
Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals.
Journal:
JAMA Intern Med
182(1):83-86
Publish Date:
2022-01-01
Author Profiles:
Against Our Instincts: Decriminalization of Buprenorphine.
Journal:
J Am Board Fam Med
35(2):394-397
Publish Date:
2022-01-01
Author Profiles:
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
Journal:
PLoS One
17(9):e0273526
Publish Date:
2022-01-01
Author Profiles:
Associations Between Copays, Coverage Limits for Naloxone, and Prescribing in Medicaid.
Journal:
Subst Abuse
16:11782218221126972
Publish Date:
2022-01-01
Author Profiles:
Could Behavioral Economics Mitigate Shortcomings in Shared Decision-Making?
Journal:
Perspect Biol Med
65(3):469-483
Publish Date:
2022-01-01
Author Profiles:
Making the Case for Accelerated Withdrawal of Aducanumab.
Journal:
J Alzheimers Dis
87(3):1003-1007
Publish Date:
2022-01-01
Author Profiles: